07/13/2020 | Press release | Distributed by Public on 07/13/2020 08:50
ATLANTA, GA - U.S. Senator David Perdue (R-GA) announced that today Georgia will receive an additional 165 cases, which includes 6,600 vials, of remdesivir, a drug which has received emergency use authorization by the U.S. Food and Drug Administration (FDA) to treat certain patients hospitalized with COVID-19.
'With critical funding from the CARES Act, the United States is working at record speed to develop effective vaccines and treatments for COVID-19,' said Senator Perdue. 'The Trump Administration is leading this effort and successfully secured a large supply of the drug remdesivir for American hospitals. Today's latest shipment of remdesivir to Georgia is welcomed news, and we will continue working to ensure COVID-19 patients in our state have access to the best possible care and treatments.'
'President Trump has struck an amazing deal to ensure Americans have access to the first authorized therapeutic for COVID-19,' said Secretary of Health and Human Services Alex Azar. 'To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump Administration is doing everything in our power to learn more about life-saving therapeutics for COVID-19 and secure access to these options for the American people.'
Through the bipartisan CARES Act and previous relief packages, Senator Perdue has helped secure nearly $18 billion in federal funding for the development of vaccines and treatments to combat COVID-19.
Hospitals receiving the vials of remdesivirwill be determined by the Georgia Department of Public Health. This will be Georgia's sixth shipment of the drug from the federal government.